ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP)

Historical Institutional Holders from Q1 2014 to Q2 2023

All holders as of June 30, 2023
Q2 2023
Type / Class
Equity / COM NEW
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q2 0 $0 -$3.2M 0
2023 Q1 27.6M $3.2M +$1.71M $0.12 44
2022 Q4 12.7M $2.16M -$33.6K $0.17 44
2022 Q3 12.8M $2.55M -$86.6K $0.20 36
2022 Q2 12.9M $6.44M -$47.9K $0.50 43
2022 Q1 12.9M $7.37M -$741K $0.57 41
2021 Q4 14.2M $8.58M -$683K $0.61 48
2021 Q3 15.1M $14.6M -$1.3M $0.97 53
2021 Q2 16.1M $17.8M +$3.21M $1.10 50
2021 Q1 12.5M $12.8M +$6.59M $0.94 50
2020 Q4 5.79M $3.8M -$773K $0.49 34
2020 Q3 6.62M $5.2M +$1.25M $0.78 43
2020 Q2 5.1M $2.74M -$387K $0.54 41
2020 Q1 6.97M $2.49M +$799K $0.36 34
2019 Q4 4.81M $3.37M -$2.97M $0.70 35
2019 Q3 9.03M $6.36M +$197K $0.70 46
2019 Q2 7.45M $9.69M -$2.69M $1.30 48
2019 Q1 9.22M $19.5M +$1.86M $2.11 54
2018 Q4 8.32M $18.7M -$6.19M $2.25 55
2018 Q3 10.6M $36.2M +$22.8M $3.50 55
2018 Q2 3.97M $12.7M +$1.59M $3.20 47
2018 Q1 3.47M $12.1M -$3.13M $3.50 50
2017 Q4 4.17M $18.4M -$8.09M $4.40 57
2017 Q3 5.55M $29M +$12.6M $5.22 45
2017 Q2 3.18M $16.5M +$1.2M $5.20 46
2017 Q1 2.99M $12.7M +$1.64M $4.25 30
2016 Q4 2.82M $8.88M -$532K $3.15 33
2016 Q3 2.87M $9.85M +$3.07M $3.43 34
2016 Q2 2M $5.61M -$3.21M $2.79 28
2016 Q1 2.6M $15.9M -$992K $6.13 27
2015 Q4 2.76M $14.9M +$288K $5.40 25
2015 Q3 2.73M $10.6M +$544K $3.88 26
2015 Q2 2.6M $10.9M +$423K $4.20 27
2015 Q1 2.49M $9.8M +$2.23M $3.94 29
2014 Q4 1.91M $11.8M -$727K $6.17 21
2014 Q3 959K $4.49M -$1.03M $4.68 19
2014 Q2 1.17M $5.65M -$3.63M $4.81 19
2014 Q1 1.67M $10.6M -$2.33M $6.36 19